SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001047469-18-004165
Filing Date
2018-05-30
Accepted
2018-05-30 17:11:46
Documents
16
Effectiveness Date
2018-05-30

Document Format Files

Seq Description Document Type Size
1 DEFM14A a2235899zdefm14a.htm DEFM14A 3372592
2 G864942.JPG g864942.jpg GRAPHIC 11974
3 G513347.JPG g513347.jpg GRAPHIC 10443
4 G730943.JPG g730943.jpg GRAPHIC 2188
5 G775862.JPG g775862.jpg GRAPHIC 3238
6 G52164.JPG g52164.jpg GRAPHIC 12642
7 G908249.JPG g908249.jpg GRAPHIC 12781
8 G28407.JPG g28407.jpg GRAPHIC 8245
9 G378180.JPG g378180.jpg GRAPHIC 7600
10 G20163.JPG g20163.jpg GRAPHIC 6245
11 G153945.JPG g153945.jpg GRAPHIC 7887
12 G670656.JPG g670656.jpg GRAPHIC 4947
13 G57492.JPG g57492.jpg GRAPHIC 23807
14 G535043.JPG g535043.jpg GRAPHIC 35521
15 G443175.JPG g443175.jpg GRAPHIC 20470
16 G824325.JPG g824325.jpg GRAPHIC 6109
  Complete submission text file 0001047469-18-004165.txt   3615491
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 000-23186 | Film No.: 18869025
SIC: 2836 Biological Products, (No Diagnostic Substances)